Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1

January 11, 2017 updated by: University of California, Los Angeles

Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules

The purpose of this protocol is to to compare the clinical utility of two dosage tapering regimens in Buprenorphine/Naloxone stabilized subjects for opiate detoxification.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment

516

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Colorado
      • Denver, Colorado, United States, 80204
        • Addiction Research & Treatment Services (ARTS)
      • Denver, Colorado, United States, 80204
        • Denver Health & Hospitals Authority
    • Connecticut
      • Hartford, Connecticut, United States, 06120
        • Hartford Dispensary
      • Waterbury, Connecticut, United States, 06705
        • Connecticut Counseling Centers
    • New York
      • Glen Oaks, New York, United States, 11004
        • LI Jewish Health System
      • New York, New York, United States, 10010
        • New York VA Medical Center
    • North Carolina
      • Raleigh, North Carolina, United States, 27610
        • South Light-Wakeview Clinic
      • Wilmington, North Carolina, United States, 28412
        • Coastal Horizons Center, Inc.
    • Oregon
      • Portland, Oregon, United States, 97214
        • CODA
    • Virginia
      • Norfolk, Virginia, United States, 23505
        • Norfolk CSB
    • Washington
      • Everett, Washington, United States, 98201
        • Providence Behavioral Health Services

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 99 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Females are not pregnant or lactating
  • Subjects meet DSM-IV criteria for opiate dependence, are medically and psychiatrically stable, and do not have a current history of benzodiazepine dependence abuse, dependence, or treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Opiate abstinence

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of California, Los Angeles

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2003

Primary Completion (Actual)

May 1, 2005

Study Completion (Actual)

May 1, 2005

Study Registration Dates

First Submitted

February 19, 2004

First Submitted That Met QC Criteria

February 19, 2004

First Posted (Estimate)

February 20, 2004

Study Record Updates

Last Update Posted (Estimate)

January 12, 2017

Last Update Submitted That Met QC Criteria

January 11, 2017

Last Verified

April 1, 2010

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NIDA-CTN-0003-1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe